Publications

Strengthening resilience to emerging vector-borne diseases in Europe: lessons learnt from countries facing endemic transmission.

Charnley, GE C; Alcayna, T; Almuedo-Riera, A; Antoniou, C; Badolo, A; Bartumeus, F; Boodram, L-L; Bueno-Marí, R; Codeço, C; Codeço Coelho, F; Costa, F; Cox, H; Haddad, N; Hamid, NA; Kittayapong, P; Korukluoğlu, G; Michaelakis, A; Maciel-de-Freitas, R; Montalvo, T; Muñoz, J; Oliveras, SS; Palmer, JR B; Barboza Pizard, CJ; Ribeiro, GS; LOWE, R;

2025

The Lancet regional health. Europe, (2025).53, 10.1016/j.lanepe.2025.101271.

Estimating contamination effects on measured trial results in TB active case finding cluster randomised trials.

LEGRAND, K; CLARK, R; KHAN, P; WHITE, R; MCCREESH, N;

2025

(2025). 10.17037/PUBS.04675881.

Spatial multilevel analysis of individual, household, and community factors associated with COVID-19 vaccine hesitancy in the Dominican Republic.

Kiani, B; Sartorius, B; Martin, BM; Cadavid Restrepo, A; Mayfield, HJ; Paulino, CT; Jarolim, P; De St Aubin, M; Ramm, RS; Dumas, D; Garnier, S; Etienne, MC; Peña, F; Abdalla, G; KUCHARSKI, A; Duke, W; Baldwin, M; Henríquez, B; De la Cruz, L; Nilles, EJ; Lau, CL;

2025

Scientific reports, (2025).15 1 10.1038/s41598-025-94653-3.

Urban Aedes aegypti suitability indicators: a study in Rio de Janeiro, Brazil.

Knoblauch, S; Mukaratirwa, RT; Pimenta, PF P; De A Rocha, AA; Yin, MS; Randhawa, S; Lautenbach, S; Wilder-Smith, A; Rocklöv, J; BRADY, OJ; Biljecki, F; Dambach, P; Jänisch, T; Resch, B; Haddawy, P; Bärnighausen, T; Zipf, A;

2025

The Lancet Planetary Health, (2025).9 4 10.1016/S2542-5196(25)00049-X.

Analysis insights to support the use of wastewater and environmental surveillance data for infectious diseases and pandemic preparedness.

O'REILLY, KM; Wade, MJ; Farkas, K; Amman, F; Lison, A; Munday, JD; Bingham, J; Mthombothi, ZE; Fang, Z; Brown, CS; Kao, RR; Danon, L;

2025

Epidemics, (2025).51, 10.1016/j.epidem.2025.100825.

The EpiFusion Analysis Framework for joint phylodynamic and epidemiological analysis of outbreak characteristics.

JUDGE, C; BRADY, O; Hill, S;

2025

F1000Research, (2025).14, 10.12688/f1000research.162719.1.

simulist: Simulate Disease Outbreak Line List and Contacts Data.

Lambert, JW; Tamayo, C; Gruson, H; Gupte, PR; Kucharski, AJ; Hartgerink, C; FUNK, S;

2025

, Comprehensive R Archive Network (2025).

Thinking fast and slow: the urgency of crisis response must not lead us to overlook chronic needs such as tuberculosis.

Dodd, PJ; VAN ZANDVOORT, K; CHECCHI, F; Khan, U; Haqmal, M; KHAN, P; MCQUAID, CF;

2025

BMJ global health, (2025).10 3 10.1136/bmjgh-2024-018012.

Population impact of new TB vaccines may depend on efficacy against infectious asymptomatic TB: a modelling study.

TANVIR, H; CLARK, R; SUMNER, T; HORTON, K; Prŷs-Jones, T; Bakker, R; Rade, K; Mave, V; Hatherill, M; Churchyard, G; HOUBEN, RM G J; WHITE, R;

2025

medRxiv (2025). 10.1101/2025.03.24.25323816.

Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines.

HODGSON, D; Liu, Y; Carolan, L; Mahanty, S; Subbarao, K; Sullivan, SG; Fox, A; KUCHARSKI, A;

2025

Frontiers in immunology, (2025).16, 10.3389/fimmu.2025.1487066.